| | Characteristics | Total (n = 47) |
| | Age, y, median (IQR) | 13 (12–18) |
| | Sex | | Female, n (%) | 27 (57%) | | Male, n (%) | 20 (43%) |
| | Race | | | Black, n (%) | 7 (13%) | | White, n (%) | 15 (32%) | | Latino, n (%) | 25 (40%) |
| | Obesity (BMI > 30), n (%) | 13 (27.6%) |
| | Comorbidities | | Respiratory, n (%) | 9 (19.1%) | | Hematologic/malignancy/immunosuppression, n (%) | 2 (4.2%) | | Diabetes/prediabetes/endocrine | 5 (10.6%) | | Neurologic/psychiatric, n (%) | 11 (23.4%) | | 2 or more comorbidities, n (%) | 6 (12.7%) |
| | Presenting symptoms/history (n = 47) | | Cough, n (%) | 16 (34%) | | Fever, n (%) | 21 (45%) | | Shortness of breath, n (%) | 11 (23.4%) | | Headache, n (%) | 3 (6.4%) | | Rhinorrhea, n (%) | 2 (4.2%) | | Nausea/vomiting, n (%) | 9 (19.1%) | | Diarrhea, n (%) | 4 (8.5%) | | Myalgias, n (%) | 2 (4.2%) |
| | Admission diagnosis (n = 47) | | Respiratory failure n (%) | 15 (32%) | | Shock, n (%) | 3 (6.4%) | | Pneumonia, n (%) | 37 (79%) | | Dka, n (%) | 2 (4.2%) | | Seizures, n (%) | 5 (13.2%) |
|
|
